Cardiovascular and Hematological Agents in Medicinal Chemistry

Aims & Scope

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents.

Each issue contains a series of timely in-depth/mini reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry.

Cardiovascular & Hematological Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cardiovascular & hematological drug discovery.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.339

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	44

Journal Rank

Year	Value
2024	15447

Journal Citation Indicator

Year	Value
2024	96

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Anthracycline-Induced Cardiotoxicity

  Citation: 141

  Authors: A., L., B.

• The Biochemical and Physical Process of Fibrinolysis and Effects of Clot Structure and Stability on the Lysis Rate

  Citation: 126

  Authors: J., R.

• Cardiotoxicity of 5-Fluorouracil

  Citation: 122

  Authors: P., M., M., J., B.

• Anticancer Properties of Flavonoids: Roles in Various Stages of Carcinogenesis

  Citation: 114

  Authors: Nicolas, Sebastien, Maria, Ramaroson

• Human Plasma Kallikrein-Kinin System: Physiological and Biochemical Parameters

  Citation: 108

  Authors: J., Z.

• Imidazoline Receptors, Novel Agents and Therapeutic Potential

  Citation: 108

  Authors: G., D.

• Pathophysiology of Myocardial Infarction and Acute Management Strategies

  Citation: 102

  Authors: Miha, Dusan, Daniel

• The Involvement of Blood Coagulation Factor XIII in Fibrinolysis and Thrombosis

  Citation: 99

  Authors: L., Z., Z., E.

• Polydeoxyribonucleotide (PDRN): A Safe Approach to Induce Therapeutic Angiogenesis in Peripheral Artery Occlusive Disease and in Diabetic Foot Ulcers

  Citation: 92

  Authors: Domenica, Alessandra, Francesca, Herbert, Letteria, Vincenzo, Natasha, Giulia, Francesco

• Female Sexual Dysfunction: Therapeutic Options and Experimental Challenges

  Citation: 75

  Authors: Kyan, Rita, R.

---